EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis

Fang Cao iD, AoNan Liu, Jiaoyang Tong, Cui Guo, Hui Zhang, Yaobin Pang, Kexin Tang, Qianying Yu, Jing Guo

mSystems · 2026

DOI: 10.1128/msystems.01403-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSystems, 2026. Verfasst von Fang Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Skin, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Provincial central of Traditional Chinese Medicine, Central and Local Goverments Lead the Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut-skin axis represents a critical but poorly understood pathway in atopic dermatitis (AD) pathogenesis. This study aimed to establish causal relationships between gut microbiota and AD risk while identifying key molecular bridges and therapeutic targets. We integrated multiple analytical approaches, including single-cell RNA sequencing analysis of skin biopsies from five AD patients and four healthy controls, intercellular communication network analysis, pseudotime trajectory inference, reverse drug prediction, molecular docking, and molecular dynamics simulations. Analysis revealed increased keratinocyte heterogeneity and enhanced immune cell communication in atopic dermatitis (AD) samples. Intersection analysis between gut microbial metabolite-associated genes and skin pathology-related genes identified seven key bridging genes ( AKR1C2 , GALE , GGH , NR4A1 , PLA2G4B , TYMS ). Functional annotation indicated that these genes are primarily involved in vitamin precursor metabolism, suggesting that the Eubacterium eligens group influences AD pathogenesis mainly through vitamin precursor-mediated pathways that regulate systemic immune responses. Pseudotime trajectory analysis demonstrated dynamic temporal gene expression patterns during disease progression. Molecular docking revealed an unexpectedly high-affinity binding between methotrexate and GALE (binding energy = −10.4 kcal/mol), which exceeded its binding affinity for the classical target TYMS (−7.5 kcal/mol). Molecular dynamics simulations further confirmed the stable binding conformation of the protein-ligand complexes. This study provides mechanistic insights into how the Eubacterium eligens group influences atopic dermatitis through vitamin precursor-mediated systemic immune modulation and identifies GALE as a novel therapeutic target. The findings provide mechanistic insights into the gut-skin axis and support developing precision medicine approaches integrating microbiome interventions with targeted pharmacotherapy for AD management. IMPORTANCE Genetic-level evidence of gut microbiota causality in atopic dermatitis: this study established a causal relationship between specific gut microbiota and the risk of atopic dermatitis at the genetic level, providing strong genetic evidence for the “gut-skin axis” theory. GALE is identified as a novel therapeutic target with redefined methotrexate mechanism: molecular docking study unexpectedly found that GALE binding affinity of MTX was significantly higher than that of its classical target TYMS, suggesting that GALE may be an important but previously unrecognized target of MTX in the treatment of AD. Multi-omics integration framework reveals increased keratinocyte heterogeneity: integrating single-cell RNA sequencing and computational pharmacology provided a cellular and molecular basis for understanding the characteristics of chronicity and recurrence of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicSkinGastrointestinal MicrobiomeHumansMolecular Docking SimulationMultiomicsMolecular Dynamics SimulationMethotrexateFemale

Stichwörter der Autor:innen

atopic dermatitisbioinformaticscomputational pharmacologygut microbiotagut-skin axis

Substanzen

Methotrexate

Autor:innen und Institutionen

  • Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Rheumatology and Immunology, First Affiliated Hospital of Army Military Medical University, Chongqing, China.

ORCID-Profile: Fang Cao

Förderung

  • National Natural Science Foundation of China
  • Sichuan Provincial central of Traditional Chinese Medicine
  • Central and Local Goverments Lead the Project

Zitieren

APA

Cao, F., Liu, A., Tong, J., Guo, C., Zhang, H., Pang, Y., Tang, K., Yu, Q., & Guo, J. (2026). Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis. mSystems. https://doi.org/10.1128/msystems.01403-25

Vancouver

Cao F, Liu A, Tong J, Guo C, Zhang H, Pang Y, et al. Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis. mSystems. 2026. doi:10.1128/msystems.01403-25

BibTeX
@article{Cao2026,
  author = {Cao, Fang and Liu, AoNan and Tong, Jiaoyang and Guo, Cui and Zhang, Hui and Pang, Yaobin and Tang, Kexin and Yu, Qianying and Guo, Jing},
  title = {Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis},
  journal = {mSystems},
  year = {2026},
  doi = {10.1128/msystems.01403-25}
}
Kostenlos starten →